Clinical trials for Wolfram syndrome neurodegeneration: Novel design, endpoints, and analysis models.
<h4>Objective</h4>Wolfram syndrome, an ultra-rare condition, currently lacks effective treatment options. The rarity of this disease presents significant challenges in conducting clinical trials, particularly in achieving sufficient statistical power (e.g., 80%). The objective of this st...
Saved in:
| Main Authors: | Guoqiao Wang, Zhaolong Adrian Li, Ling Chen, Heather Lugar, Tamara Hershey |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0321598 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sodium valproate, a potential repurposed treatment for the neurodegeneration in Wolfram syndrome (TREATWOLFRAM): trial protocol for a pivotal multicentre, randomised double-blind controlled trial
by: Una Martin, et al.
Published: (2025-02-01) -
Case report: hyponatraemia in Wolfram syndrome
by: Khadijah Tukur, et al.
Published: (2025-07-01) -
Blood biomarkers as surrogate endpoints in Alzheimer’s disease research
by: Guogen Shan, et al.
Published: (2025-05-01) -
Gonadal Dysfunction in Wolfram Syndrome: A Prospective Study
by: Gema Esteban-Bueno, et al.
Published: (2025-06-01) -
Association of optic atrophy and type 1 diabetes: clinical hallmarks for the diagnosis of Wolfram syndrome
by: José Luiz Pedroso, et al.
Published: (2015-05-01)